ARCT — Arcturus Therapeutics Holdings Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapMomentum Trap
- $415.94m
- $238.00m
- $12.36m
Annual cashflow statement for Arcturus Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.9 | -21.8 | -26 | -72.1 | -204 |
| Depreciation | |||||
| Non-Cash Items | 2.67 | 1.6 | 2.88 | 7.19 | 36.2 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 7.36 | -1.16 | 16 | 21.2 | 31.2 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.46 | -20.8 | -6.45 | -42.9 | -135 |
| Capital Expenditures | -0.251 | -1.48 | -0.818 | -1.74 | -3.41 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 10.6 | 23.6 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 10.4 | 22.1 | -0.818 | -1.74 | -3.41 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7 | 10.2 | 41.9 | 436 | 48 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16.9 | 11.6 | 34.6 | 392 | -90.4 |